Abstract:Abstract Introduction Sleep deficiencies, such as manifested in short sleep duration or insomnia symptoms, are known to increase the risk for multiple chronic diseases. Inflammation is considered a mechanism through which deficient sleep acts as risk factor for these diseases. Thus, mitigating inflammation might be a potential way to diminish negative health consequences related to sleep deficiency. To investigate a pharmacological approach for this, we used low-dose acetylsalicylic acid (ASA, aspirin), known for its counter-inflammatory actions including the cyclooxygenase (COX)-, NF-kB-, and resolution-pathways. Our aim was to investigate whether low-dose ASA can blunt the pro-inflammatory response to experimental sleep restriction. Methods 46 healthy adults (19F/27M, 19-63 years) participated in a randomized placebo-controlled crossover trial with 3 protocols each consisting of a 14-day at-home phase followed by an 11-day (10-night) in-hospital stay (sleep restriction/ASA, sleep restriction/placebo, control sleep/placebo). In the sleep restriction/ASA condition, participants took low-dose ASA (81 mg/day) during the at-home phase and in-hospital stay. Each in-hospital stay started with 2 nights of 8h-sleep opportunity. Then, under the sleep restriction conditions, participants were exposed to 5 nights of 4h-sleep opportunity, followed by 3 nights of recovery sleep (8h/night). The control sleep condition provided 8h-sleep opportunity throughout the in-hospital stay. Sleep and immunologic/hematologic measures were assessed at baseline, after the 5th night of sleep restriction/control sleep, and after the 2nd night of recovery sleep. Generalized linear mixed models were used for analysis. Results Administration of low-dose ASA reduced interleukin (IL)-6 expression (p<.05 for condition*day) and COX-1/COX-2 double positive cells in lipopolysaccharide (LPS)-stimulated monocytes (p<.05 for condition) as well as C-reactive protein (CRP) serum levels (p<.01 for condition) in the sleep restriction condition compared to placebo. Baseline comparisons revealed no differences between conditions (p>.05 for condition). Conclusion The results show that preemptive administration of low-dose ASA can reduce pro-inflammatory responses to experimental sleep restriction in humans. These findings may open new therapeutic approaches to prevent or control inflammation and its consequences in those experiencing periods of sleep deficiency. Support (if any) NIH/NHLBI R01-HL136310; NIH/NCRR UL1-RR02758, M01-RR01032; German Research Foundation (DFG) EN1291/1-1; SRSF Career Development Award.

Probiotics Supplementation Attenuates Inflammation and Oxidative Stress Induced by Chronic Sleep Restriction

Probiotics Administration Alleviates Cognitive Impairment and Circadian Rhythm Disturbance Induced by Sleep Deprivation

Nicotinic Mitigation of Neuroinflammation and Oxidative Stress After Chronic Sleep Deprivation

Effects of prebiotics on intestinal physiology, neuropsychological function, and exercise capacity of mice with sleep deprivation

Melatonin prevents the dysbiosis of intestinal microbiota in sleep-restricted mice by improving oxidative stress and inhibiting inflammation

Lacticaseibacillus rhamnosus GG alleviate sleep deprivation induced-intestinal barrier dysfunction and neuroinflammation in mice

Probiotics, Anticipation Stress, and the Acute Immune Response to Night Shift

Gut microbiota modulates the inflammatory response and cognitive impairment induced by sleep deprivation

The effect of probiotic supplementation on sleep, depression-like behaviour, and central glucose and lactate metabolism in male and female pubertal mice exposed to chronic sleep disruption

Lactiplantibacillus plantarum 124 Modulates Sleep Deprivation-Associated Markers of Intestinal Barrier Dysfunction in Mice in Conjunction with the Regulation of Gut Microbiota

Targeting Microbiota to Alleviate the Harm Caused by Sleep Deprivation

A probiotic NVP1704 alleviates stress-induced sleeplessness/depression-like symptoms in mice by upregulating serotonergic and GABAergic systems and downregulating NF-κB activation

The relationship between gut microbiota and inflammatory response, learning and memory in mice by sleep deprivation

Sleep deprivation-induced anxiety-like behaviors are associated with alterations in the gut microbiota and metabolites

Bifidobacterium breve CCFM1025 Improves Sleep Quality via Regulating the Activity of the HPA Axis: A Randomized Clinical Trial

Melatonin Alleviates Oxidative Stress in Sleep Deprived Mice: Involvement of Small Intestinal Mucosa Injury

0174 Using Low-Dose Acetylsalicylic Acid to Target Inflammation in Response to Experimental Sleep Restriction in Humans

Faecalibacterium prausnitzii Supplementation Prevents Intestinal Barrier Injury and Gut Microflora Dysbiosis Induced by Sleep Deprivation

Chronic sleep loss alters the inflammatory response and BDNF expression in C57BL/6J mice

Improvements in sleep indices during exam stress due to consumption of a Bifidobacterium longum

Ozone rectal insufflation mitigates chronic rapid eye movement sleep deprivation-induced cognitive impairment through inflammation alleviation and gut microbiota regulation in mice